The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.

When: 3rd Tuesday of every month, 9:00 am

Where: Zoom

20 S. Penn Street, Baltimore, MD 21201

CME Credit: One (1)

Contact: 410-328-7516, Note: If you would like to meet with the speaker, please contact Florence Wade.

Upcoming Frontiers in Oncology Seminars 

September 9, 2020 – 9:00 am – Zoom Virtual Seminar

Leslie S. Kean, M.D., Ph.D.

Director, Stem Cell Transplant Center
Dana Farber/Boston Children’s Cancer and Blood Disorders Center
Division of Hematology/Oncology
Robert A. Stranahan Professor of Pediatrics
Harvard Medical School
Boston, MA

"Applying Big Data to Little Patients:  The Systems Biology of Graft Versus Host Disease"

October 20, 2020 – 9:00 am – Zoom Virtual Seminar

Ross L. Levine, M.D.

Chief, Molecular Cancer Medical Service
The Human Oncology and Pathogenesis Program (HOPP)
Member HOPP Leukemia Service
Professor of Medicine, Weil Cornell Medicine
Laurence Joseph Dineen Chair in Leukemia Research
Program Member, CCSG
Memorial Sloan Kettering Cancer Center
New York, NY

“Deciphering and Targeting Clonal Evolution and Myeloid Transformation”

November 24, 2020 – 9:00 am – Virtual Zoom Seminar

Michael M. Shen, Ph.D.

Director of Graduate Studies
Professor of Medicine, Genetics & Development,
Urology and Systems Biology
Columbia University Medical Center
Professor of Medicine, Weil Cornell Medicine
Herbert Irving Comprehensive Cancer Center
New York, NY

“Differentiation and Transdifferentiation in Prostate Development and Cancer"

December 15, 2020 – 9:00 am – Virtual Zoom Seminar

Wenye Wei, Ph.D.

Professor, Department of Pathology
Director, Biochemistry Program
Cancer Research Institute, BIDMC Cancer Center
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

“Targeting Cell Signaling Pathways for Cancer Therapies."